Abstract
ADAMTS8 (A Disintegrin-like and Metalloproteinase with Thrombospondin motifs 8) is a secreted zinc-dependent metalloproteinase whose expression is downregulated in a variety of solid tumors. Xenografts expressing high levels of ADAMTS8 have a poor capacity to invade and migrate in nude mice. While this data highlights a beneficial, anti-cancerogenic role of ADAMTS8, the mechanism behind this activity is still not fully elucidated. So far, the only reported substrate for ADAMTS8 is osteopontin (OPN), an extracellular matrix protein widely implicated in multiple steps of cancer progression, albeit, similar to other ADAMTS family members, it is very likely that ADAMTS8 cleaves a variety of substrates. The availability of purified ADAMTS8 may enlighten the biological role of this metalloproteinase.
Here we describe methods for expression and purification of recombinant ADAMTS8 in HEK293T cells as well as a convenient assay to test ADAMTS8 proteolytic activity using OPN as a substrate.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Huxley-Jones J, Apte SS et al (2005) The characterisation of six ADAMTS proteases in the basal chordate Ciona intestinalis provides new insights into the vertebrate ADAMTS family. Int J Biochem Cell Biol 37:1838–1845
Santamaria S, Martin DR, Dong X et al (2021) Post-translational regulation and proteolytic activity of the metalloproteinase ADAMTS8. J Biol Chem 297:101323
Vázquez F, Hastings G, Ortega MA et al (1999) METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J Biol Chem 274:23349–23357
Georgiadis KE, Hirohata S, Seldin MF et al (1999) ADAM-TS8, a novel metalloprotease of the ADAM-TS family located on mouse chromosome 9 and human chromosome 11. Genomics 62:312–315
Omura J, Satoh K, Kikuchi N et al (2019) ADAMTS8 promotes the development of pulmonary arterial hypertension and right ventricular failure: a possible novel therapeutic target. Circ Res 125:884–906
Dunn JR, Panutsopulos D, Shaw MW et al (2004) METH-2 silencing and promoter hypermethylation in NSCLC. Br J Cancer 91:1149–1154
Dunn JR, Reed JE, du Plessis DG et al (2006) Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours. Br J Cancer 94:1186–1193
Rodríguez-Rodero S, Fernández AF, Fernández-Morera JL et al (2013) DNA methylation signatures identify biologically distinct thyroid cancer subtypes. J Clin Endocrinol Metab 98:2811–2821
Drilon A, Sugita H, Sima CS et al (2014) A prospective study of tumor suppressor gene methylation as a prognostic biomarker in surgically resected stage I to IIIA non-small-cell lung cancers. J Thorac Oncol 9:1272–1277
Choi CGC, Li J, Wang Y, Li L et al (2014) The metalloprotease ADAMTS8 displays antitumor properties through antagonizing EGFR-MEK-ERK signaling and is silenced in carcinomas by CpG methylation. Mol Cancer Res 12:228–238
Li Y, Xiao X, Ji X et al (2015) RNA-seq analysis of lung adenocarcinomas reveals different gene expression profiles between smoking and nonsmoking patients. Tumour Biol 36:8993–9003
Zhao X, Yang C, Wu J et al (2018) ADAMTS8 targets ERK to suppress cell proliferation, invasion, and metastasis of hepatocellular carcinoma. Onco Targets Ther 11:7569–7578
Chen J, Zhang J, Li X et al (2016) Downregulation of ADAMTS8 by DNA hypermethylation in gastric cancer and its clinical significance. Biomed Res Int 2016:5083841
Lim SB, Tan SJ, Lim WT et al (2017) An extracellular matrix-related prognostic and predictive indicator for early-stage non-small cell lung cancer. Nat Commun 8:1734
Zhang Y, He RQ, Dang YW et al (2016) Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells. Cancer Cell Int 16:89
Lee HC, Chang CY, Wu KL et al (2022) The therapeutic potential of ADAMTS8 in lung adenocarcinoma without targetable therapy. J Pers Med 12:902
Tan Y, Zhao L, Yang YG et al (2022) The role of osteopontin in tumor progression through tumor-associated macrophages. Front Oncol 12:953283
Chen L, Huan X, Xiao GH et al (2022) Osteopontin and its downstream carcinogenic molecules: regulatory mechanisms and prognostic value in cancer progression. Neoplasma 69:1253–1269
Kuno K, Matsushima K (1998) ADAMTS-1 protein anchors at the extracellular matrix through the thrombospondin type I motifs and its spacing region. J Biol Chem 273:13912–13917
Acknowledgments
The Santamaria lab is supported by the British Heart Foundation (FS/IBSRF/20/25032).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Burkhard, T., Minns, A.F., Santamaria, S. (2024). Expression and Purification of Recombinant ADAMTS8. In: Santamaria, S. (eds) Proteases and Cancer. Methods in Molecular Biology, vol 2747. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3589-6_5
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3589-6_5
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3588-9
Online ISBN: 978-1-0716-3589-6
eBook Packages: Springer Protocols